TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

MAP Pharmaceuticals Inc. (NASDAQ:MAPP) Investor Files Lawsuit Against Takeover By Allergan, Inc

  • If you purchased shares of MAP Pharmaceuticals Inc. (NASDAQ:MAPP) prior to January 22, 2013, and currently hold any of those NASDAQ:MAPP shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Feb. 04, 2013 (Shareholders Foundation) -- An investor in shares of MAP Pharmaceuticals Inc. (NASDAQ:MAPP) filed a lawsuit in effort to stop the proposed takeover of MAP Pharmaceuticals Inc by Allergan, Inc for $25.00 per NASDAQ:MAPP share. The plaintiff alleges that the defendants breached their fiduciary duties owed NASDAQ:MAPP stockholders by agreeing to sell the company too cheap...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: